Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ferumoxytol-enhanced MRV in Venous System Diseases
NCT07452250Phase 2Recruiting
- Sponsor
- Min Zhou
- Start
- Mar 2026
- Primary completion
- Aug 2026
- Modality
- Nanoparticles, Small Molecules
- Countries
- 1
01
Overview
Phase 2, single-blind, single-arm trial of ferumoxytol in venous disease, sponsored by Min Zhou. Primary endpoint: Overall Diagnostic Success Rate. Started Mar 2026; status: recruiting.
02
Drugs
ferumoxytol
03
Conditions
venous disease
Beyond the preview
Go deeper on NCT07452250.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07452250.